SEARCH

SEARCH BY CITATION

References

  • Algarzae N., Hebron M., Miessau M. and Moussa C. E. (2012) Parkin prevents cortical atrophy and Abeta-induced alterations of brain metabolism: (1)(3)C NMR and magnetic resonance imaging studies in AD models. Neuroscience 225, 2234.
  • Arai T., Hasegawa M., Akiyama H. et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602611.
  • Burns M. P., Zhang L., Rebeck G. W., Querfurth H. W. and Moussa C. E. (2009) Parkin promotes intracellular Abeta1-42 clearance. Hum. Mol. Genet. 18, 32063216.
  • Cookson M. R. and Bandmann O. (2010) Parkinson's disease: insights from pathways. Hum. Mol. Genet. 19, R21R27.
  • Deng H., Dodson M. W., Huang H. and Guo M. (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl Acad. Sci. USA 105, 1450314508.
  • Dickson D. W., Josephs K. A. and Amador-Ortiz C. (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol. 114, 7179.
  • Ellison D. W., Beal M. F., Mazurek M. F., Bird E. D. and Martin J. B. (1986) A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann. Neurol. 20, 616621.
  • Fukuda M., Moreira J. E., Liu V., Sugimori M., Mikoshiba K. and Llinas R. R. (2000) Role of the conserved WHXL motif in the C terminus of synaptotagmin in synaptic vesicle docking. Proc. Natl Acad. Sci. USA 97, 1471514719.
  • Geser F., Brandmeir N. J., Kwong L. K., Martinez-Lage M., Elman L., McCluskey L., Xie S. X., Lee V. M. and Trojanowski J. Q. (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 65, 636641.
  • Gingras A. C., Raught B., Gygi S. P. et al. (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15, 28522864.
  • Goldberg M. S., Fleming S. M., Palacino J. J. et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 4362843635.
  • Greenamyre J. T., Penney J. B., Young A. B., D'Amato C. J., Hicks S. P. and Shoulson I. (1985) Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science 227, 14961499.
  • Grolleau A., Bowman J., Pradet-Balade B., Puravs E., Hanash S., Garcia-Sanz J. A. and Beretta L. (2002) Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem. 277, 2217522184.
  • Hasegawa M., Arai T., Nonaka T. et al. (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 6070.
  • Hebron M. L., Lonskaya I., Sharpe K., Weerasinghe P. P., Algarzae N. K., Shekonyan A. R. and Moussa C. E. (2013) Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J. Biol. Chem. 288, 41034115.
  • Helton T. D., Otsuka T., Lee M. C., Mu Y. and Ehlers M. D. (2008) Pruning and loss of excitatory synapses by the parkin ubiquitin ligase. Proc. Natl Acad. Sci. USA 105, 1949219497.
  • Herman A. M., Khandelwal P. J., Stanczyk B. B., Rebeck G. W. and Moussa C. E. (2011) beta-amyloid triggers ALS-associated TDP-43 pathology in AD models. Brain Res. 1386, 191199.
  • Herman A. M., Khandelwal P. J., Rebeck G. W. and Moussa C. E. (2012) Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Exp. Neurol. 235, 297305.
  • Herningtyas E. H., Okimura Y., Handayaningsih A. E., Yamamoto D., Maki T., Iida K., Takahashi Y., Kaji H. and Chihara K. (2008) Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line. Biochim. Biophys. Acta 1780, 11151120.
  • Huber K. M., Kayser M. S. and Bear M. F. (2000) Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288, 12541257.
  • Huynh D. P., Scoles D. R., Nguyen D. and Pulst S. M. (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet. 12, 25872597.
  • Jiang C. and Schuman E. M. (2002) Regulation and function of local protein synthesis in neuronal dendrites. Trends Biochem. Sci. 27, 506513.
  • Kang H. and Schuman E. M. (1996) A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273, 14021406.
  • Khandelwal P. J., Herman A. M., Hoe H. S., Rebeck G. W. and Moussa C. E. (2011) Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models. Hum. Mol. Genet. 20, 20912102.
  • Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y. and Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605608.
  • Klann E. and Dever T. E. (2004) Biochemical mechanisms for translational regulation in synaptic plasticity. Nat. Rev. Neurosci. 5, 931942.
  • Kwiatkowski T. J., Jr, Bosco D. A., Leclerc A. L. et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 12051208.
  • Lagier-Tourenne C., Polymenidou M., Hutt K. R. et al. (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15, 14881497.
  • Leggett C., McGehee D. S., Mastrianni J., Yang W., Bai T. and Brorson J. R. (2012) Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices. J. Neurol. Sci. 317, 6673.
  • Leigh P. N., Whitwell H., Garofalo O., Buller J., Swash M., Martin J. E., Gallo J. M., Weller R. O. and Anderton B. H. (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114(Pt 2), 775788.
  • Lucking C. B., Durr A., Bonifati V. et al. (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med. 342, 15601567.
  • Mackenzie I. R., Bigio E. H., Ince P. G. et al. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427434.
  • Mackenzie I. R., Rademakers R. and Neumann M. (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 9951007.
  • Mamane Y., Petroulakis E., Rong L., Yoshida K., Ler L. W. and Sonenberg N. (2004) eIF4E–from translation to transformation. Oncogene 23, 31723179.
  • Martin K. C., Casadio A., Zhu H., Yaping E., Rose J. C., Chen M., Bailey C. H. and Kandel E. R. (1997) Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function for local protein synthesis in memory storage. Cell 91, 927938.
  • Matsumura T., Morinaga Y., Fujitani S., Takehana K., Nishitani S. and Sonaka I. (2005) Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver. Hepatol. Res. 33, 2732.
  • McCluskey L. F., Elman L. B., Martinez-Lage M., Van Deerlin V., Yuan W., Clay D., Siderowf A. and Trojanowski J. Q. (2009) Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. Arch. Neurol. 66, 121124.
  • Mitchell J. D. and Borasio G. D. (2007) Amyotrophic lateral sclerosis. Lancet 369, 20312041.
  • Moussa Cel H., Mitrovic A. D., Vandenberg R. J., Provis T., Rae C., Bubb W. A. and Balcar V. J. (2002) Effects of L-glutamate transport inhibition by a conformationally restricted glutamate analogue (2S,1′S,2′R)-2-(carboxycyclopropyl)glycine (L-CCG III) on metabolism in brain tissue in vitro analysed by NMR spectroscopy. Neurochem. Res. 27, 2735.
  • Moussa C. E., Rae C., Bubb W. A., Griffin J. L., Deters N. A. and Balcar V. J. (2007) Inhibitors of glutamate transport modulate distinct patterns in brain metabolism. J. Neurosci. Res. 85, 342350.
  • Neumann M., Sampathu D. M., Kwong L. K. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130133.
  • Neumann M., Kwong L. K., Sampathu D. M., Trojanowski J. Q. and Lee V. M. (2007a) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch. Neurol. 64, 13881394.
  • Neumann M., Mackenzie I. R., Cairns N. J. et al. (2007b) TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 66, 152157.
  • Ou S. H., Wu F., Harrich D., Garcia-Martinez L. F. and Gaynor R. B. (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 35843596.
  • Periquet M., Corti O., Jacquier S. and Brice A. (2005) Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J. Neurochem. 95, 12591276.
  • Perry T. L., Hansen S. and Jones K. (1987) Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 37, 18451848.
  • Plaitakis A. and Caroscio J. T. (1987) Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 22, 575579.
  • Polymenidou M., Lagier-Tourenne C., Hutt K. R. et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459468.
  • Poole A. C., Thomas R. E., Yu S., Vincow E. S. and Pallanck L. (2010) The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS ONE 5, e10054.
  • Quinlan K. A. (2011) Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis. Integr. Comp. Biol. 51, 913925.
  • Rae C., Moussa Cel H., Griffin J. L., Bubb W. A., Wallis T. and Balcar V. J. (2005) Group I and II metabotropic glutamate receptors alter brain cortical metabolic and glutamate/glutamine cycle activity: a 13C NMR spectroscopy and metabolomic study. J. Neurochem. 92, 405416.
  • Rae C., Moussa Cel H., Griffin J. L., Parekh S. B., Bubb W. A., Hunt N. H. and Balcar V. J. (2006) A metabolomic approach to ionotropic glutamate receptor subtype function: a nuclear magnetic resonance in vitro investigation. J. Cereb. Blood Flow Metab. 26, 10051017.
  • Rahn K. A., Slusher B. S. and Kaplin A. I. (2012) Glutamate in CNS neurodegeneration and cognition and its regulation by GCPII inhibition. Curr. Med. Chem. 19, 13351345.
  • Rothstein J. D. (1995) Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 3, 348359.
  • Sau D., Rusmini P., Crippa V., Onesto E., Bolzoni E., Ratti A. and Poletti A. (2011) Dysregulation of axonal transport and motorneuron diseases. Biol. Cell 103, 87107.
  • Schiavo G., Stenbeck G., Rothman J. E. and Sollner T. H. (1997) Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses. Proc. Natl Acad. Sci. USA 94, 9971001.
  • Sears D. D., Hsiao G., Hsiao A., Yu J. G., Courtney C. H., Ofrecio J. M., Chapman J. and Subramaniam S. (2009) Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc. Natl Acad. Sci. USA 106, 1874518750.
  • Shima H., Pende M., Chen Y., Fumagalli S., Thomas G. and Kozma S. C. (1998) Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17, 66496659.
  • Shimura H., Hattori N., Kubo S. et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302305.
  • Tanaka A. (2010) Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett. 584, 13861392.
  • Tanaka A., Cleland M. M., Xu S., Narendra D. P., Suen D. F., Karbowski M. and Youle R. J. (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 191, 13671380.
  • Tollervey J. R., Curk T., Rogelj B. et al. (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452458.
  • Tsai K. J., Yang C. H., Fang Y. H. et al. (2010) Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J. Exp. Med. 207, 16611673.
  • Vance C., Rogelj B., Hortobagyi T. et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 12081211.
  • Vincent A., Briggs L., Chatwin G. F. et al. (2012) parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress. Hum. Mol. Genet. 21, 17601769.
  • Wils H., Kleinberger G., Janssens J. et al. (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 107, 38583863.
  • Wilson J. M. and Shaw C. A. (2007) Late appearance of glutamate transporter defects in a murine model of ALS-parkinsonism dementia complex. Neurochem. Int. 50, 10671077.
  • Yoshiyama Y., Higuchi M., Zhang B. et al. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337351.
  • Young A. B. and Penney J. B. (1984) Neurochemical anatomy of movement disorders. Neurol. Clin. 2, 417433.
  • Zhang Y. J., Xu Y. F., Cook C. et al. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 106, 76077612.
  • Zheng M., Liao M., Cui T., Tian H., Fan D. S. and Wan Q. (2012) Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN. J. Cell Sci. 125, 15561567.
  • Ziviani E., Tao R. N. and Whitworth A. J. (2010) Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl Acad. Sci. USA 107, 50185023.